Holen Sie sich die Stockscreener-App
16.18
4.59%
0.7222
Finanzdaten der Summit Therapeutics Inc-Aktie (SMMT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
3.96%
224.93
|
234.21 | 568.44 | 66.85 | 65.82 |
| Nonoperating Income/Loss |
137.92%
5.753
|
2.418 | 2.729 | 3.938 | 13.10 |
| Income/Loss From Continuing Operations Before Tax |
5.44%
-219.17
|
-231.79 | -565.71 | -62.91 | -61.20 |
| Income/Loss From Continuing Operations After Tax |
5.44%
-219.17
|
-231.79 | -565.71 | -62.91 | -61.20 |
Net Income/Loss
|
5.44%
-219.17
|
-231.79 | -565.71 | -62.91 | -61.20 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.15%
6.3137
|
743.42 | 742.62 | 738.08 | 6.3735 |
| Diluted Average Shares |
99.15%
6.3137
|
743.42 | 742.62 | 738.08 | 6.3735 |
| Basic Earnings Per Share |
9.68%
-0.28
|
-0.31 | -0.76 | -0.09 | -0.09 |
| Diluted Earnings Per Share |
9.68%
-0.28
|
-0.31 | -0.76 | -0.09 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):